Literature DB >> 33181242

Advances in the profiling of N6-methyladenosine (m6A) modifications.

Hong-Xiang Zheng1, Xian-Sheng Zhang2, Na Sui3.   

Abstract

Over 160 RNA modifications have been identified, including N7-methylguanine (m7G), N6-methyladenosine (m6A), and 5-methylcytosine (m5C). These modifications play key roles in regulating the fate of RNA. In eukaryotes, m6A is the most abundant mRNA modification, accounting for over 80% of all RNA methylation modifications. Highly dynamic m6A modification may exert important effects on organismal reproduction and development. Significant advances in understanding the mechanism of m6A modification have been made using immunoprecipitation, chemical labeling, and site-directed mutagenesis, combined with next-generation sequencing. Single-molecule real-time and nanopore direct RNA sequencing (DRS) approaches provide additional ways to study RNA modifications at the cellular level. In this review, we explore the technical history of identifying m6A RNA modifications, emphasizing technological advances in detecting m6A modification. In particular, we discuss the challenge of generating accurate dynamic single-base resolution m6A maps and also strategies for improving detection specificity. Finally, we outline a roadmap for future research in this area, focusing on the application of RNA epigenetic modification, represented by m6A modification.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  N(6)-methyladenosine; Nanopore DRS; Next-generation sequencing; SMRT; m(6)A-mapping

Mesh:

Substances:

Year:  2020        PMID: 33181242     DOI: 10.1016/j.biotechadv.2020.107656

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  18 in total

1.  m6A Regulator-Mediated Methylation Modification Patterns and Characterisation of Tumour Microenvironment Infiltration in Non-Small Cell Lung Cancer.

Authors:  Yongfei Fan; Yong Zhou; Ming Lou; Xinwei Li; Xudong Zhu; Kai Yuan
Journal:  J Inflamm Res       Date:  2022-03-23

Review 2.  RNA 5-methylcytosine modification and its emerging role as an epitranscriptomic mark.

Authors:  Yaqi Gao; Jingyuan Fang
Journal:  RNA Biol       Date:  2021-07-21       Impact factor: 4.766

Review 3.  Novel insights into the m6A-RNA methyltransferase METTL3 in cancer.

Authors:  Yiqing Cai; Rui Feng; Tiange Lu; Xiaomin Chen; Xiangxiang Zhou; Xin Wang
Journal:  Biomark Res       Date:  2021-04-20

4.  Low Expression of YTH Domain-Containing 1 Promotes Microglial M1 Polarization by Reducing the Stability of Sirtuin 1 mRNA.

Authors:  Hongxiu Zhou; Zongren Xu; Xingyun Liao; Shiyun Tang; Na Li; Shengping Hou
Journal:  Front Cell Neurosci       Date:  2021-12-15       Impact factor: 5.505

Review 5.  Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer.

Authors:  Qiang Liu
Journal:  Front Genet       Date:  2022-01-11       Impact factor: 4.599

6.  The bioinformatics and experimental analysis of AlkB family for prognosis and immune cell infiltration in hepatocellular carcinoma.

Authors:  Bi Peng; Yuanliang Yan; Zhijie Xu
Journal:  PeerJ       Date:  2021-09-01       Impact factor: 2.984

Review 7.  The role of RNA m5C modification in cancer metastasis.

Authors:  Qiaofeng Zhang; Furong Liu; Wei Chen; Hongrui Miao; Huifang Liang; Zhibin Liao; Zhanguo Zhang; Bixiang Zhang
Journal:  Int J Biol Sci       Date:  2021-08-02       Impact factor: 6.580

8.  RNA m6A Methylation Regulators Multi-Omics Analysis in Prostate Cancer.

Authors:  Hao Su; Yutao Wang; Hongjun Li
Journal:  Front Genet       Date:  2021-11-26       Impact factor: 4.599

Review 9.  m6A RNA Methylation in Systemic Autoimmune Diseases-A New Target for Epigenetic-Based Therapy?

Authors:  Anna Wardowska
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-05

Review 10.  Targeting Epigenetic Mechanisms in Vascular Aging.

Authors:  Zhongxiao Lin; Qian Ding; Xinzhi Li; Yuliang Feng; Hao He; Chuoji Huang; YiZhun Zhu
Journal:  Front Cardiovasc Med       Date:  2022-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.